The largest database of trusted experimental protocols

10 protocols using luna pfp

1

Purification of R. schneideri Poison Extract

Check if the same lab product or an alternative is used in the 5 most similar protocols

Ten milligrams of the methanolic extract of R. schneideri poison was dissolved in 40 µL of amonium bicarbonate completing the volume to 100 µL using trifluoracetic acid (TFA) 0.1% and centrifugated (14000 g, 3 min, 4°C) to remove the insoluble material. The supernatant was used for purification.
The methanolic extract was fractioned by HPLC on a reversed phase Phenomenex Luna PFP (250 x 4.6 mm) with TFA 0.1% + acetonitrile (ACN) 10% as mobile phase and ACN 90% + 0.1% TFA as eluent. Fractions were eluted with a linear gradient 0-65% of eluent. The outflow was monitored at 214 e 280 nm. The fractions were manually collected and then lyophilized.9 (link)
+ Open protocol
+ Expand
2

Determination of Cadophorin Stereochemistry

Check if the same lab product or an alternative is used in the 5 most similar protocols
A sample of cadA and cadB (approximately 0.5 mg) were dissolved in 2.0 mL of 6 M hydrochloric acid and hydrolyzed overnight at 110 °C. The hydrolysates were treated with Marfey’s reagent (FDNP-Val-NH2) as previously reported [31 (link)]. The derivatives were analysed by LC–DAD–MS (column: Luna PFP, 3 μm, 2.0 mm × 100 mm; Phenomenex, Torrance, CA, USA), set at 28 °C. The mobile phase was H2O containing 0.1% formic acid (A) and ACN (B), at a flow rate of 0.3 mL/min. A linear gradient elution was performed as follows: 25% B (3 min), 25–65% B (3–40 min), 100% B (41–45 min), 25% B (45–50 min).
The same procedure was repeated for cadophorin B (0.2 mg) to confirm the results.
+ Open protocol
+ Expand
3

Quantification of Glutathione Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
GSH levels were measured in plasma and platelets after 30 min incubation of PRP with and without NAC, exogenous GSH, or GSH ethyl ester (GSHO-Et). Platelets were then isolated by centrifugation (700× g for 15 min) and washed with phosphate buffered saline (PBS). Intracellular and plasma GSH levels were quantified using a LC-MS/MS method previously developed and validated by us [32 (link)]. Briefly, chromatographic separation was conducted on a Luna PFP analytical column (100 × 2.0 mm, 3 µm, Phenomenex, Castel Maggiore, Bologna, Italy), eluted at 35 °C under isocratic conditions at 200 µL/min by 1% methanol in ammonium formate 0.75 mmol/L adjusted to pH 3.5 with formic acid. Analysis was performed by an Accela chromatographic system coupled with a triple quadrupole mass spectrometer TSQ Quantum Access (Thermo Fisher Scientific, Rodano, Milan, Italy) using an electrospray ionization source in positive ion mode. The transitions used in the multiple reaction monitoring were m/z 308.1→m/z 76.2 + 84.2 + 161.9. Data were obtained by comparison with calibration curves using GSH standard solutions (Sigma-Aldrich S.r.l.). The intra- and inter-day CVs % obtained with standard samples were <5%. The limits of detection were 0.031 µmol/L. Levels of GSH were expressed as μmol/L concentration and data are reported as mean ± SD.
+ Open protocol
+ Expand
4

HPLC Analysis of Complex Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HPLC devices (Jasco, Gross-Umstadt, Germany) consisted of the following equipment: binary high-pressure HPLC pump system (PU-2080 Plus), autosampler (AS-2055), degasser (DG-2080-53; 3-line), DAD (diode array detection) detector (MD-2010 Plus) or UV/VIS detector (UV-2075), and injection valve (Rh 7725i type Rheodyne; Bensheim, Germany). Chromatographic gradient development and peak separation was performed on an analytical 250 × 4.6 mm, 5 µm Luna® phenyl-hexyl column (Phenomenex Ltd., Aschaffenburg, Deutschland) or Luna® pentafluorophenyl column (Phenomenex Ltd., Aschaffenburg, Deutschland). Furthermore, (sub)fractionation was carried out through chromatographic separation on a preparative 250 × 21.2 mm Luna® phenyl-hexyl column with a particle size of 5 µm (Phenomenex Ltd., Aschaffenburg, Deutschland) and a semipreparative 250 × 10 mm, 5 µm Luna® PFP (Phenomenex Ltd., Aschaffenburg, Deutschland) or a semipreparative 250 × 10 mm, 5 µm Luna® phenyl-hexyl column (Phenomenex Ltd., Aschaffenburg, Germany). Each column was attached to a suitable precolumn. The analyzed data was processed by ChromPass (version 1.9; Jasco Groß-Umstadt, Germany) or Galaxie software (version 1.10; Agilent Technologies, Oberhaching, Germany).
+ Open protocol
+ Expand
5

Analytical Method for HBCDD Determination

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analyses of HBCDDs were performed on a Chronet Symbiosys Plus HPLC system (Axel Semrau, Sprockhövel, Germany) coupled to Sciex 6500+ triple quadrupole mass spectrometer (AB Sciex, Darmstadt, Germany). The mass spectrometer was operated in negative electrospray ionisation mode.
During method development, two analytical columns were tested: Phenomenex Luna PFP (150 × 2 mm, 3 µm particles) and Luna C18 (150 × 2 mm, 3 µm particles), held at 30 and 40 °C. Mobile phase flow was set at 0.2 mL/min. Analytes were separated using binary gradient system consisting of methanol:water (75:25, v/v) (A) and acetonitrile (B). Initial composition 80% A was held for 1.00 min, followed by linear decrease in the next 1.00 min to 45% A, held at 45% A for 9.0 min and returned to initial conditions in 0.1 min. Injection volume was 70 µL.
In the optimised method, temperature of the ion source was kept at 300 °C, ion spray voltage was −4500 V, whereas optimised curtain, nebulising, drying and collision gas were 35.0, 35.0, 50.0 and 10.0 psig N2, respectively.
For native HBCDDs, two transitions per parent m/z were monitored, while only one transition was monitored for their labelled analogues. Selected MRM transitions and optimised parameters are presented in Table 2.
+ Open protocol
+ Expand
6

HPLC Analysis of Strychnos Alkaloids

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HPLC system was from Agilent (Machelen, Belgium). The models were: G1313A for the samples compartment (ALS), G1311A for the quaternary pump, G1322A for degasser, G1316A for column compartment (TCC), and G7117B for DAD. A Luna® PFP from Phenomenex (250 × 4.6 mm, 5 μm) (Utrecht, Netherlands) was used as an analytical column with a flow rate of 1 mL/min. The gradient variated from 5% B to 25.4% B between 2 and 3 min, from 25.4% to 83.2% B between 3 and 37 min, and from 83.2% B to 100% B between 37 and 38 min. After maintaining 100% B for 1 min, the gradient was returned to the initial stage (Solution A was water + 0.05% TFA, and solution B was methanol).
The concentrations of injected solutions were at 10 mg/mL and 175 μg/mL for extracts of the ten Strychnos species and strychnine reference, respectively. The injected volume was 10 μL, and the DAD detector was set at 254 nm.
+ Open protocol
+ Expand
7

HPLC Analysis of Micotheca albicans

Check if the same lab product or an alternative is used in the 5 most similar protocols
Aliquots of the extracts and phases of M. albicans (10 mg each) were separately dissolved in 10 mL of MeOH − H2O (1:1) and filtered through 0.22 μm PVDF membranes (Allcrom, Brazil). Subsequently, 10 μL aliquots of each solution were separately injected into a Luna RP-18 column [5.0 µm; 150 × 2.0 mm; Phenomenex™ Luna PFP (2), USA] coupled to a sub-2 Security Guard Ultra Cartridge for C18 HPLC and a core − shell column (2.1 mm, Phenomenex, USA). Column temperature was maintained at 50 °C, and the mobile phase, at a flow of 0.2 mL/min, consisted of a linear gradient of water (solvent A) and methanol (solvent B), both containing 0.1% (v/v) of formic acid, as follows: 3% B (0 − 2 min), 3 − 25% B (2 − 25 min), 25 − 80% B (25 − 40 min), 80% B (40 − 43 min), followed by washing and reconditioning of the column (80% B → 3% B, 8 min). The DAD acquisitions were performed in the range of 240 − 800 nm. The data obtained were subsequently processed and analyzed using the DataAnalysis® software version 4.2 (Bruker).
+ Open protocol
+ Expand
8

HPLC Analysis of Cigarette Smoke Phenols

Check if the same lab product or an alternative is used in the 5 most similar protocols
The procedure followed was the HPLC phenol compound analysis method for mainstream cigarette smoke by the Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA, Paris, France) [11 ], with the following modifications. Standards were prepared over a range of 0.05–10 μg/mL in mobile phase. All EC liquid samples were analysed at a 10-fold dilution in mobile phase. An Agilent Model 1100, High Performance Liquid Chromatograph was equipped with a fluorescence detector operating at an excitation of 280 nm and an emission at 310 nm and a Phenomenex Luna PFP, 4.6 × 150 mm, 3u column. The limit of detection was 0.05 μg/mL for all phenols.
The materials used for the analysis were: deionized water, Millipore; methanol HPLC Grade, Sigma-Aldrich (P/N 34860); hydroquinone (CAS #123-31-9), Alfa Aesar (Ward Hill, MA, USA) P/N A11411); resorcinol (CAS #108-46-3), Sigma-Aldrich (P/N 398047); catechol (CAS #120-80-9), Alfa Aesar (P/N A10164); phenol (CAS #108-95-2), Alfa Aesar (P/N A15760); m-cresol (CAS #108-39-4), Sigma-Aldrich, (P/N C85727); o-cresol (CAS #95-48-7), Sigma-Aldrich (P/N C85700); p-cresol (CAS #106-44-5), Alfa Aesar (P/N A13531).
+ Open protocol
+ Expand
9

Quantification of Berberine in Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
DIO mice were i.p injected with 5 mg/kg BBR. After 1 h, the animals were sacrificed and plasma, liver, different adipose depots, and muscle were collected and preserved at −80 °C. Tissue samples were analyzed with LC-MS/MS system (Agilent 1200 HPLC coupled to Agilent 6460 Triple Quad instrument, Agilent Technologies, USA) to detect the concentration of BBR. Samples were disrupted with methanol before analysis. The chemicals were firstly separated on Luna PFP (50 × 2.0 mm, 5 μm, Phenomenex) using mixture of methanol-0.1% formic acid and 5 mmol/L ammonium acetate solution (55:45, v/v) with following rate (0.65 ml/min, 0–5 min RT). The chemicals with m/z 336 and 320 were analyzed using electrospray ionization mode with capillary voltage setting to 4 kV. The drying gas temperature was 350 °C with a flow rate of 10 L/min, and the sheath gas temperature was 350 °C with a flow rate of 11 L/min. Data were analyzed by MassHunter Quantitative Analysis (version B.02.01, Agilent Technologies).
+ Open protocol
+ Expand
10

Anthranilic Acid Derivatives Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analyses to detect anthranilic acid derivatives were performed on a Dionex Ultimate 3000 RSLC system using a Phenomenex Luna PFP, 100 x 2.0 mm, 3 mm dp column. Separation of 1 mL sample was achieved by a linear gradient with (A) H 2 O + 0.1 % FA to (B) ACN + 0.1 % FA at a flow rate of 600 mL/min and 45 C. The gradient was initiated by a 1 min isocratic step at 2 % B, followed by an increase to 95 % B in 9 min to end up with a 1.5 min step at 95 % B before reequilibration under the initial conditions. UV spectra were recorded by a DAD in the range from 200 to 600 nm. The LC flow was split to 75 mL/min before entering the solariX XR (7T) FT-ICR mass spectrometer (Bruker Daltonics, Germany) using the Apollo ESI source. In the source region, the temperature was set to 200 C, the capillary voltage was 4500 V, the dry-gas flow was 4.0 L/min and the nebulizer was set to 1.1 bar. After the generated ions passed the quadrupole with a low cutoff at 150 m/z they were trapped in the collision cell for 100 ms and finally transferred within 1.0 ms through the hexapole into the ICR cell. Captured ions were excited by applying a frequency sweep from 100 to 1600 m/z and detected in broadband mode by acquiring a 489 ms transient.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!